| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 222.50M | 160.10M | 129.70M | 155.70M | 219.20M |
| Gross Profit | 200.00M | 92.00M | 61.50M | 69.90M | 157.80M |
| EBITDA | 20.30M | 5.40M | -10.30M | 4.10M | 82.00M |
| Net Income | 46.00M | 8.60M | -38.30M | -6.90M | 61.20M |
Balance Sheet | |||||
| Total Assets | 535.90M | 358.00M | 373.20M | 384.00M | 565.90M |
| Cash, Cash Equivalents and Short-Term Investments | 447.00M | 187.60M | 290.00M | 246.80M | 375.30M |
| Total Debt | 273.60M | 109.50M | 69.50M | 66.10M | 237.40M |
| Total Liabilities | 307.50M | 141.50M | 126.40M | 100.00M | 277.90M |
| Stockholders Equity | 228.40M | 216.50M | 246.80M | 284.00M | 288.00M |
Cash Flow | |||||
| Free Cash Flow | -34.40M | -70.30M | -37.70M | -24.30M | 90.70M |
| Operating Cash Flow | -33.80M | -67.40M | -25.60M | -10.40M | 100.10M |
| Investing Cash Flow | -126.20M | 23.30M | 66.40M | 162.00M | 310.90M |
| Financing Cash Flow | 124.70M | 10.20M | 3.70M | -201.70M | -291.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £39.55M | 3.46 | 8.28% | ― | 11.71% | 31.15% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £95.17M | 2.45 | 12.38% | ― | 17.35% | 91.55% | |
62 Neutral | £11.96M | 4.32 | 14.61% | 3.33% | 8.91% | 94.32% | |
61 Neutral | £193.00M | 2.44 | -965.56% | 4.74% | ― | ― | |
58 Neutral | £12.35M | 2.46 | ― | ― | 30.78% | ― | |
55 Neutral | £405.64M | 8.64 | 21.54% | ― | 7.90% | ― |